Dash Acquisitions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
1,312
-216
-14% -$221K 0.32% 33
2026
Q1
$1.41M Buy
1,528
+40
+3% +$40.6K 0.29% 35
2025
Q4
$1.65M Sell
1,488
-1
-0.1% -$956 0.34% 34
2025
Q3
$1.21M Buy
1,489
+1,004
+207% +$747K 0.24% 38
2025
Q2
$387K Buy
485
+13
+3% +$10.1K 0.08% 41
2025
Q1
$352K Buy
472
+88
+23% +$73.2K 0.08% 41
2024
Q4
$309K Buy
384
+16
+4% +$13.2K 0.07% 42
2024
Q3
$329K Hold
368
0.08% 41
2024
Q2
$334K Sell
368
-5
-1% -$4K 0.09% 38
2024
Q1
$280K Buy
373
+41
+12% +$29.2K 0.09% 41
2023
Q4
$209K Buy
+332
New +$194K 0.07% 44

Other funds holding LLY

Dash Acquisitions's LLY Position: Q2 2026 in Review

Dash Acquisitions reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $221K and leaving 1,312 shares worth $1.6M. The position accounts for 0.32% of the portfolio, ranked #33.

Dash Acquisitions first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.65M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dash Acquisitions held 1,312 shares of Eli Lilly worth $1.6M as of Q2 2026.
  • Dash Acquisitions sold 216 Eli Lilly shares in Q2 2026, an estimated $221K.
  • Eli Lilly made up 0.32% of Dash Acquisitions's portfolio in Q2 2026, its #33 holding.
  • Dash Acquisitions first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Dash Acquisitions's Eli Lilly position peaked at $1.65M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dash Acquisitions's 13F filing for Q2 2026, filed 13 Aug 2026.